Government
Hundreds of thousands of current, emerging and minority suppliers all in one place
Suppliers
Be found by thousands of government buyers by highlighting keywords, category codes and capabilities
REGENERON PHARMACEUTICALS
PSF Verified777 Old Saw Mill River Road, Tarrytown, NY 10591, United States
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept injection for subcutaneous use; ZALTR...
DUNS #:
194873139
CAGE Code:
544P9
Type:
Manufacturer
Employees:
5,000-10,000
Annual Revenue:
$1B-$10B
Year Founded:
1988
Country of Origin:
United States
Sectors Served:
US Federal
Company Security Level:
Unknown
Credit Card Usage:
No
Specialties and Expertise:
Biopharma, Biotechnology, Pharmaceutical, Cardiovascular, Metabolic Disorders, Diseases, Inflammation, Immunology, Oncology, Immuno-Oncology, Antibody Drug Conjugates (ADCs), Anti-Vascular Endothe...COVID-19 Supplies1
Are you making PPE or ventilators for COVID-19?
Let us knowCategories
Products Available
Inventory/Capacity
Certification
Available Contracts
Contact Info
Vaccines and Therapeutics
Kevzara
no data
no data
no data
Contact/Location Info5
Government POC
Government POC
Government POC
Size and minority status
Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)
Commodity Codes3
PRODUCTS AND SERVICES4
VelocImmune
2 past experiences
VelocImmune creates optimized antibody drug candidates from immunized mice and produces fully human antibodies therapeutics.
VelociT technology
1 past experience
VelociT technology is used for the production of fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens.
Regeneron Genetics Center
Regeneron Genetics Center is an integrated large-scale genomics program that uses DNA sequencing and analysis to discover and develop drugs for the treatment of rare diseases.
Kevzara
1 past experience
Kevzara is a fully-human monoclonal antibody for rheumatoid arthritis that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. The med is on clinical trails to combat Covid-19 coronavirus infection.
Past experience3
other
Kevzara to treat severe Covid-19
Sanofi and Regeneron Pharmaceuticals have started a clinical trial program evaluating Kevzara a rheumatoid arthritis drug to treat h...
other
Antibodies Discovery, Development and Produ...
HHS and Regeneron signed an agreement in 2017 to discover, research, develop and manufacture antibodies targeting up to ten pathogen...
other
Ebola Outbreak Antibody Therapeutic
VelocImmune technology previously leveraged to develop a three-antibody therapeutic to fight against the Ebola outbreak in the Democ...
External Recognition1
Known Locations Served1
My Notes
